American Portfolios Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $55.8K | Hold |
947
| – | – | ﹤0.01% | 1634 |
|
|
2022
Q2 | $54.7K | Hold |
947
| – | – | ﹤0.01% | 1710 |
|
|
2022
Q1 | $58.7K | Sell |
947
-66
| -7% | -$4.09K | ﹤0.01% | 1803 |
|
|
2021
Q4 | $72.1K | Hold |
1,013
| – | – | ﹤0.01% | 1693 |
|
|
2021
Q3 | $75.8K | Buy |
1,013
+133
| +15% | +$9.95K | ﹤0.01% | 1572 |
|
|
2021
Q2 | $68.1K | Buy |
880
+67
| +8% | +$5.18K | ﹤0.01% | 1575 |
|
|
2021
Q1 | $60K | Buy |
813
+100
| +14% | +$7.38K | ﹤0.01% | 1538 |
|
|
2020
Q4 | $50K | Buy |
713
+83
| +13% | +$5.82K | ﹤0.01% | 1411 |
|
|
2020
Q3 | $35.7K | Buy |
630
+244
| +63% | +$13.8K | ﹤0.01% | 1451 |
|
|
2020
Q2 | $22.5K | Buy |
386
+186
| +93% | +$10.8K | ﹤0.01% | 1595 |
|
|
2020
Q1 | $9.3K | Sell |
200
-200
| -50% | -$9.3K | ﹤0.01% | 1842 |
|
|
2019
Q4 | $22.3K | Hold |
400
| – | – | ﹤0.01% | 1677 |
|
|
2019
Q3 | $18.9K | Hold |
400
| – | – | ﹤0.01% | 1681 |
|
|
2019
Q2 | $21.4K | Sell |
400
-125
| -24% | -$6.69K | ﹤0.01% | 1638 |
|
|
2019
Q1 | $29K | Buy |
525
+200
| +62% | +$11K | ﹤0.01% | 1423 |
|
|
2018
Q4 | $15.3K | Sell |
325
-200
| -38% | -$9.41K | ﹤0.01% | 1477 |
|
|
2018
Q3 | $31.2K | Hold |
525
| – | – | ﹤0.01% | 1314 |
|
|
2018
Q2 | $28.7K | Hold |
525
| – | – | ﹤0.01% | 1307 |
|
|
2018
Q1 | $25.8K | Hold |
525
| – | – | ﹤0.01% | 1295 |
|
|
2017
Q4 | $24.8K | Buy |
+525
| New | +$24.8K | ﹤0.01% | 1257 |
|